Hostname: page-component-77c89778f8-m42fx Total loading time: 0 Render date: 2024-07-22T22:33:55.987Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic induced blepharospasm and its treatment with botulinum toxin type A

Published online by Cambridge University Press:  13 June 2014

Hagen Rampes  and
Ashok G Patel
Hagen Rampes
Affiliation:
South Bedfordshire Community Health Care Trust, Fairfield Hospital, Stotfold, Near Hitchin Hertfordshire, SG5 4A, England
Ashok G Patel
Affiliation:
South Bedfordshire Community Health Care Trust, Fairfield Hospital, Stotfold, Near Hitchin Hertfordshire, SG5 4A, England
Get access Rights & Permissions [Opens in a new window]

Abstract

Three cases of neuroleptic induced blepharospasm successfully treated by botulinum toxin type A are reported.

Keywords

BlepharospasmBotulinum toxin type ANeuroleptic
Type
Clinical and Brief Reports
Information
Irish Journal of Psychological Medicine , Volume 12 , Issue 2 , June 1995 , pp. 64 - 65
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Scott, AB. Botulinum toxin injections into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044–9.CrossRefGoogle ScholarPubMed
2.National Institutes of Health. Clinical use of botulinum toxin: consensus conference. Connecticut Medicine 1991; 55: 471–7.Google Scholar
3.Grandas, F, Elston, J, Quinn, N, Marsden, CD. Blepharospasm: A review of 264 patients. J Neurol Neurosurg Psychiatr 1988; 51(6): 767–72.CrossRefGoogle ScholarPubMed
4.Jankovic, J, Ford, J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983; 13: 402–11.CrossRefGoogle ScholarPubMed
5.Jankovic, J, Patel, SC. Blepharospasm associated with brain stem lesions. Neurology 1983; 33: 1237–40.CrossRefGoogle Scholar
6.Ananth, J, Edelmuth, E, Dargan, B. Meige's syndrome associated with neuroleptic treatment. Am J Psychiatry 1988; 145: 513–5.Google ScholarPubMed
6a.Weiner, WJ, Nausieda, PA, Glantz, RH. Meige syndrome (Blepharospasm-oromondibular dystonia) after long term neuroleptic therapy. Neurology 1981 1555–6.Google Scholar
7.Jimenez-Jimenez, FJ, Garcia-Albea, E, Vaquero-Ruiperez, JA, Tejeiro, J, CabreraValdivia, F, Ayuso-Peralta, L. Reading as a “trick” for relieving blepharospasm. Movement Disorders 1992; 7: 186CrossRefGoogle Scholar
8.Fielding, R. Self control training in blepharospasm. Lancet 1989; 8637: 548–9.CrossRefGoogle Scholar
9.Surwit, RS, Rotberg, M. Biofeedback therapy of essential blepharospasm. Am J Ophthalmol 1984; 98: 28–31.CrossRefGoogle ScholarPubMed
10.Murphy, JK, Fuller, AK. Hypnosis and biofeedback as adjunctive therapy in blepharospasm: a case report. Am J Clin Hypnosis 1984; 27: 31–7.CrossRefGoogle ScholarPubMed
11.Greene, P. Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992 15: 276–88.CrossRefGoogle ScholarPubMed
12.Sandyk, R. Blepharospasm…successful treatment with baclofen and sodium valproate. A case report. SAMJ 1983; 64: 955–6.Google ScholarPubMed
13.Wirtschafter, JD. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm. Ophthalmology 1991; 98(3): 357–66.CrossRefGoogle ScholarPubMed
14.Nutt, JG, Hammerstad, JP, Degarmo, P, Carter, J. Cranial dystonia: double blind crossover study of anticholinergics. Neurology 1984; 34: 215–7.CrossRefGoogle ScholarPubMed
15.Fasanella, RM, Aghajanian, GK. Treatment of benign essential blepharospasm with cyproheptadine. New Engl J Med 1990; 322(11): 778Google ScholarPubMed
16.Ballard, CG. Successful therapeutic intervention in a schizophrenic patient with blepharospasm. J Neurol Neurosurg Psychiatr 1989; 52(11): 1312CrossRefGoogle Scholar
17.Bird, AC, Macdonald, WI. Essential blepharospasm. Trans Am Ophthalmol Soc 1975; 95: 250–3.Google ScholarPubMed
18.Lang, AE, Riley, DE. Tizanidine in cranial dystonia. Clin Neuropharmacol 1992; 15: 142–7.CrossRefGoogle ScholarPubMed
19.Moss, L. Prosthesis for blepharospasm. J Am Optomet Assoc 1983; 54(12) 1071–3.Google ScholarPubMed
20.Sold-Darseff, J and Leydhecker, W. Acupuncture for pain in the cranial region and for blepharospasm without organic cause. Klinische Monatblatter Fur Augenheilkunde 1986; 189(2): 167–9.CrossRefGoogle ScholarPubMed
21.Wielka, J, Swietliczkowa, I, Szusterowska-Martinowa, E. Acupuncture in the treatment for benign essential blepharospasm. Klinika Oczna 1983; 85(8–9): 313–5.Google Scholar
22.Clarke, CE. Therapeutic potential of botulinum toxin in neurological disorders. Quart J Med 1992; 299: 197–205.Google Scholar
23.Corridan, P, Nightingale, S, Masoudi, N, Williams, AC. Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol 1990; 74(5): 309–10.CrossRefGoogle ScholarPubMed
24.Glanzman, RL, Gelb, DJ, Druly, I, Bromberg, MB, Truong, DD. Brachial plexopathy after botulinum toxic injections. Neurology 1990; 40: 1143CrossRefGoogle Scholar
25.Haug, BA, Dressler, D, Prange, HW. Polyradiculoneuritis following botulinum toxin therapy. J Neurol 1990; 237: 62–3.CrossRefGoogle ScholarPubMed
26.Tsui, JK, Wong, NLM, Wong, E, Calne, DB. Production of circulating antibodies to botulinum A toxin in patients receiving repeated injections for dystonia. Ann Neurol 1988; 24: 181.Google Scholar